Classes
Publications
- Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization2023 | First Faculty of Medicine
- Monitoring EBV infection, MSI, PDL-1 expression, Her-2/neu amplification as a biomarker for PD-1 inhibition in gastric cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- Deep membrane proteome profiling reveals overexpression of prostate-specific membrane antigen (Psma) in high-risk human paraganglioma and pheochromocytoma, suggesting new theranostic opportunity2021 | First Faculty of Medicine
- Clinical importance of her-3 in breast cancer2020 | First Faculty of Medicine, Third Faculty of Medicine
- Molecular mechanisms and signaling pathways in pancreatic carcinoma2018 | First Faculty of Medicine, Third Faculty of Medicine
- Molecular pathological predictive diagnostics in a patient with non-small cell lung cancer treated with crizotinib therapy: A case report2017 | First Faculty of Medicine, Second Faculty of Medicine
- The use of 5-FU pharmacogenomics from paraffin blocks in patients with breast cancer receiving fluorouracil therapy2015 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Detection of chromosome changes by CGH, array-CGH and SNP array techniques in tumours2014 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers2013 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
Loading network view...